Artelo Biosciences, Inc. (ARTL) — 分析师展望 / 分析师共识目标价为. 基于 4 位分析师评级, 共识为 看涨 — 2 买入, 2 持有.
分析师预估 每股收益(EPS)为 $-11.82 和 营收为 $0.00B (下一财年).
每股收益(EPS)历史表现: 2024: 实际 $-1.02 vs 预期 $-11.82 (超预期 +91.4%). 2025: 实际 $-5.47 vs 预期 $-36.33 (超预期 +84.9%). 分析师准确度: 0%.
ARTL 分析师评级
Buy
基于过去3个月内 4 位分析师对 Artelo Biosciences, Inc. 的评级
EPS 预测 — ARTL
0%
Analyst Accuracy
Inaccurate
2 years compared
Actual vs Estimate
2024
Actual –$1.02
vs Est –$11.82
▲ 1,062.7% off
2025
Actual –$5.47
vs Est –$36.33
▲ 564.2% off
Profitability Outlook
Company has been making losses in all recent fiscal years. Analysts expect losses to continue near-term.
营收预测 — ARTL
Revenue Trend
Revenue has been relatively flat. Analysts expect stable revenue going forward.
